ZHER2 Affibody as a Good Candidate for Detection of Metastatic Prostate Cancer

  • Mahboobeh Nazari Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  • Ramin Radmanesh Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
DOI: https://doi.org/10.18502/ajmb.v13i3.6366
Keywords: Prostate cancer, Positron Emission Tomography (PET), ZHER2 affibody

Abstract

The article abstract is not available.

Published
2021-06-13
Issue
Volume (13) issue (3)
Section
Articles